This inventor holds 1 USPTO granted patent and 8 published patent applications and 3 EPO patents. Top assignee: Sanofi. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations by Annke Hahn in Insulin Formulations
Introduction
Annke Hahn is a prominent inventor based in Frankfurt am Main, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of insulin formulations. Her innovative work has the potential to improve the management of diabetes for many patients.
Latest Patents
Annke Hahn holds a patent for "Long-acting formulations of insulin." This patent relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL of insulin glargine, which is equimolar to 200-1000 IU of human insulin. This formulation aims to provide a more effective and longer-lasting treatment option for individuals with diabetes.
Career Highlights
Throughout her career, Annke has been associated with Sanofi, a leading global healthcare company. Her work at Sanofi has allowed her to focus on innovative solutions in diabetes care, contributing to advancements in insulin delivery and formulation.
Collaborations
Annke has collaborated with notable colleagues, including Reinhard Becker and Peter Boderke. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.
Conclusion
Annke Hahn's contributions to insulin formulations exemplify the impact of innovation in healthcare. Her work not only advances medical science but also enhances the quality of life for patients managing diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile